Zynerba Pharmaceuticals 관리
관리 기준 확인 3/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Armando Anido
최고 경영자
US$1.9m
총 보상
| CEO 급여 비율 | 33.6% |
| CEO 임기 | 9yrs |
| CEO 소유권 | 1.9% |
| 경영진 평균 재임 기간 | 6.8yrs |
| 이사회 평균 재임 기간 | 8.2yrs |
최근 관리 업데이트
Recent updates
Is Zynerba Pharmaceuticals (NASDAQ:ZYNE) In A Good Position To Deliver On Growth Plans?
Mar 01
Is Zynerba Pharmaceuticals (NASDAQ:ZYNE) In A Good Position To Invest In Growth?
Nov 11Zynerba stock rises on US patent for cannabidiol Zygel's use for Fragile X syndrome
Oct 06Zynerba Pharmaceuticals GAAP EPS of -$0.24 misses by $0.01
Aug 10We Think Zynerba Pharmaceuticals (NASDAQ:ZYNE) Can Afford To Drive Business Growth
Jul 22Zynerba inks equity funding contract of up to $20M with Lincoln Park Capital
Jul 21Here's Why We're Watching Zynerba Pharmaceuticals' (NASDAQ:ZYNE) Cash Burn Situation
Mar 23We Think Zynerba Pharmaceuticals (NASDAQ:ZYNE) Can Afford To Drive Business Growth
Dec 02We Think Zynerba Pharmaceuticals (NASDAQ:ZYNE) Can Afford To Drive Business Growth
May 27Zynerba Pharma shares slip 10% on Zygel update in Fragile X syndrome
Dec 17Is Zynerba Pharmaceuticals (NASDAQ:ZYNE) In A Good Position To Invest In Growth?
Nov 23
Zynerba Pharmaceuticals EPS beats by $0.12
Nov 09Zynerba Zygel Remains A Huge Part Of The Company's Pipeline Despite Setback
Oct 29CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -US$38m |
| Mar 31 2023 | n/a | n/a | -US$37m |
| Dec 31 2022 | US$2m | US$633k | -US$35m |
| Sep 30 2022 | n/a | n/a | -US$36m |
| Jun 30 2022 | n/a | n/a | -US$38m |
| Mar 31 2022 | n/a | n/a | -US$38m |
| Dec 31 2021 | US$2m | US$603k | -US$37m |
| Sep 30 2021 | n/a | n/a | -US$38m |
| Jun 30 2021 | n/a | n/a | -US$37m |
| Mar 31 2021 | n/a | n/a | -US$47m |
| Dec 31 2020 | US$1m | US$585k | -US$51m |
| Sep 30 2020 | n/a | n/a | -US$52m |
| Jun 30 2020 | n/a | n/a | -US$45m |
| Mar 31 2020 | n/a | n/a | -US$36m |
| Dec 31 2019 | US$1m | US$568k | -US$33m |
| Sep 30 2019 | n/a | n/a | -US$30m |
| Jun 30 2019 | n/a | n/a | -US$36m |
| Mar 31 2019 | n/a | n/a | -US$37m |
| Dec 31 2018 | US$2m | US$568k | -US$40m |
| Sep 30 2018 | n/a | n/a | -US$40m |
| Jun 30 2018 | n/a | n/a | -US$41m |
| Mar 31 2018 | n/a | n/a | -US$37m |
| Dec 31 2017 | US$2m | US$552k | -US$32m |
| Sep 30 2017 | n/a | n/a | -US$31m |
| Jun 30 2017 | n/a | n/a | -US$28m |
| Mar 31 2017 | n/a | n/a | -US$26m |
| Dec 31 2016 | US$901k | US$536k | -US$23m |
보상 대 시장: Armando 의 총 보상 ($USD 1.88M )은 US 시장( $USD 647.72K ).
보상과 수익: Armando 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Armando Anido (65 yo)
9yrs
테뉴어
US$1,881,402
보상
Mr. Armando Anido, MBA, has been the Chairman and Chief Executive Officer of Zynerba Pharmaceuticals, Inc. since October 2014. Mr. Anido has been an Independent Director of SCYNEXIS, Inc. since January 21,...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Chairman & CEO | 9yrs | US$1.88m | 1.94% $ 1.3m | |
| President | 9yrs | US$1.38m | 1.18% $ 775.1k | |
| CFO & VP of Corporate Development (Leave of Absence) | 7.1yrs | US$1.26m | 0.75% $ 491.5k | |
| VP, Corporate Controller & Interim CFO | 6.6yrs | 데이터 없음 | 0.17% $ 111.2k | |
| Chief Legal Officer & Corporate Secretary | 1.7yrs | 데이터 없음 | 0.45% $ 295.1k | |
| Vice President of Human Resources | 5.6yrs | 데이터 없음 | 데이터 없음 |
6.8yrs
평균 재임 기간
59yo
평균 연령
경험이 풍부한 관리: ZYNE 의 관리팀은 노련하고 경험 (평균 재직 기간 6.8 년)입니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Chairman & CEO | 9yrs | US$1.88m | 1.94% $ 1.3m | |
| Independent Director | 8.2yrs | US$107.50k | 0.15% $ 98.5k | |
| Independent Director | 8.2yrs | US$105.00k | 0.15% $ 98.5k | |
| Lead Independent Director | 8.2yrs | US$135.00k | 0.15% $ 98.5k | |
| Independent Director | 5.5yrs | US$102.50k | 0.16% $ 105.0k | |
| Independent Director | 8.2yrs | US$110.00k | 0.15% $ 98.5k | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | 8yrs | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | 7yrs | 데이터 없음 | 데이터 없음 | |
| Independent Director | 4.7yrs | US$100.00k | 0.15% $ 98.5k | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 |
8.2yrs
평균 재임 기간
65yo
평균 연령
경험이 풍부한 이사회: ZYNE 의 이사회는 경험(평균 재직 기간 8.2 년)으로 간주됩니다.